Visual Impairment clinical trials

Explore recruiting visual impairment clinical trials.

Recruiting visual impairment studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Visual Impairment trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Early Reperfusion Therapy with Intravenous Thrombolysis for Recovery of VISION in Acute Central Retinal Artery Occlusion (REVISION) - A double-blind randomized placebo-controlled phase III trial

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

A RANDOMIZED, PHASE 3, OPEN-LABEL STUDY OF NEOADJUVANT DAROVASERTIB IN SUBJECTS WITH PRIMARY NON-METASTATIC UVEAL MELANOMA (OptimUM-10)

France, Spain, Poland, Italy, Czechia, Belgium +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

EMMA - Medico Economic Evaluation of Fluocinolone Acetonide Implant Versus Dexametheasone Implant in Resistant Diabetic Macular Oedema

France

Therapeutic use (Phase IV) EU CTIS Study details

RETINO 2018: conservative treatment for retinoblastoma: efficacy of the new management strategies and visual outcome

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A study to learn about how much emodepside gets absorbed in the blood and how food affects its absorption when given as a new type of tablet to healthy participants

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

Visual Impairment trials by city

Visual Impairment in Toronto Visual Impairment in Vancouver Visual Impairment in Montreal Visual Impairment in Calgary Visual Impairment in Edmonton Visual Impairment in Ottawa Visual Impairment in Winnipeg Visual Impairment in Quebec City Visual Impairment in Hamilton Visual Impairment in Kitchener Visual Impairment in London Visual Impairment in Halifax Visual Impairment in New York Visual Impairment in Los Angeles Visual Impairment in Chicago Visual Impairment in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease